<DOC>
	<DOCNO>NCT01873144</DOCNO>
	<brief_summary>The purpose study demonstrate heat , humidify , high-flow nasal cannula ( HHHFNC ) superior hypertonic saline solution ( HSS ) treatment moderate acute viral bronchiolitis infant improve respiratory distress comfort reduce length hospital stay ( LOS ) admission Pediatric Intensive Care Unit ( PICU ) .</brief_summary>
	<brief_title>High Flow Therapy v Hypertonic Saline Bronchiolitis</brief_title>
	<detailed_description />
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Bronchiolitis , Viral</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>Children age 6 month less Moderate ( Respiratory Distress Assessment Instrument score 4 great ) viral bronchiolitis ( defined McConnockie ) Meeting Admission criterion History prematurity Chronic lung disease Cystic fibrosis Congenital heart disease Neuromuscular disease Airway anomalies Immunodeficiency Those require immediate intubation ventilation .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Bronchiolitis</keyword>
	<keyword>Hypertonic saline solution</keyword>
	<keyword>High-flow oxygen therapy</keyword>
	<keyword>Respiratory distress</keyword>
	<keyword>Comfort</keyword>
</DOC>